Ocuphire Pharma Investor Day Presentation Deck
RM
64
●
Market Research Methodology by Global Data
Market Research Conducted in 2H 2020 for RM, Presbyopia, and Night Vision Disturbances
GlobalData conducted this research in 4 phases of primary research, which allowed us to inform the
survey instruments for each audience as the project progressed
1
Physician
Perceptions
OBJECTIVE:
Assess the
competitive
environment in
each of the three
indications from the
perspective of
treating physicians
●
Payer
Patient
Perceptions Perceptions
OBJECTIVE:
Understand the
assignment of
coverage in
pharmacy or vision
plans
3
GlobalData Market Research Survey
OBJECTIVE:
Understand patients'
current unmet needs
as well as their
potential acceptance
of or desire for Nyxol
.
Quantitative
Physician
Input
OBJECTIVE:
Quantitatively
assess the potential
use of Nyxol in each
of the three
indications
MMMM
>200 Total Patients Surveyed
Reversal of mydriasis (N=190)
Presbyopia (N=134)
Dim Light Vision Disturbance (N=120)
●
120* Optometrists &
Ophthalmologists Surveyed
(N=69 Optometrists; N=51 Ophthalmologists)
* Retina specialist were not surveyed
Ocuphire
PHARMAView entire presentation